Sponsor Pipeline

Beijing Kanghong Biological Medicine Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-22 NCT07720635 A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Active Thyroid… Phase 3 Not Yet Recruiting
2026-07-22 NCT07720648 A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Inactive Thyroid… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07720635 A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Active Thyroid… Thyroid Eye Disease Not Yet Recruiting
NCT07720648 A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Inactive Thyroid… Thyroid Eye Disease Not Yet Recruiting
Get alerts when Beijing Kanghong Biological Medicine Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free